Delivery Order SPE2DB22D2211-SPE2DB25FRVBL
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,827.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RINVOQ ER 15 MG TABLET, a medication used to treat certain medical conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. The contract is not set aside and is open to full and open competition....
This federal contract award, valued at $6,223.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a firm fixed-price delivery order contract type, is for the delivery of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $7,552.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The contract has an ultimate completion date of February 26, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order valued at $10,205.77 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, with a period of performance through March 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $17,614.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $108,961.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of RINVOQ ER 15 MG TABLET, a medication used for various medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of December 16, 2024. The award is not associated with a set-aside designation,...
This federal contract award, valued at $3,538.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of the medication RINVOQ ER 15 MG TABLET UU 30S, with an ultimate completion date of April 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $13,357.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $30,151.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $7,659.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...